Ketogenic Diets Reduce Depression and May Quiet the Mind
Multiple — metabolic psychiatry research · JAMA Psychiatry meta-analysis (2025) (2025)
A 2025 JAMA Psychiatry meta-analysis found ketogenic diets show a small-to-medium effect on reducing depressive symptoms. The mechanism: ketones increase GABA (an inhibitory neurotransmitter), reduce neural excitability, and may address mitochondrial dysfunction linked to mood disorders. An emerging field called "metabolic psychiatry" treats mental health through metabolism rather than traditional neurotransmitter manipulation.
Core Concepts
The Problem
Depression and anxiety are typically treated through SSRIs (targeting serotonin) or therapy. The metabolic psychiatry thesis suggests a different root cause: cellular energy dysfunction. If the brain's mitochondria aren't working properly, mood and cognition suffer — and dietary intervention may address this at the source.
The Claim
The 2025 JAMA Psychiatry systematic review and meta-analysis is the strongest evidence to date:
**Depression.** 10 randomized controlled trials with 631 participants. Pooled analysis showed a standardized mean difference of -0.48, indicating a small-to-medium effect favoring ketogenic diets over control diets. Studies using biochemical ketone monitoring showed larger effects (SMD -0.88).
**Anxiety.** Results were mixed — RCTs showed no significant effect, but quasi-experimental studies (6 studies) showed medium within-group improvement (SMD -0.58).
**Mechanisms.** The ketogenic diet reduces neuronal firing rates, modulates ion channels, and stimulates GABA synthesis and neurotransmission. GABA is a major inhibitory neurotransmitter — more GABA means less neural excitability, which subjectively feels like a calmer, quieter mind. Additional mechanisms include reduced neuroinflammation, improved mitochondrial function, and reduced oxidative stress.
**Alzheimer's connection.** The brain's inability to use glucose efficiently (sometimes called "Type 3 diabetes") is increasingly linked to Alzheimer's disease. Ketones provide an alternative fuel source that the brain can use even when glucose metabolism is impaired.
Key Evidence
- •2025 JAMA Psychiatry meta-analysis: 10 RCTs, 631 participants, SMD -0.48 for depression (small-to-medium effect)
- •Studies with biochemical ketone monitoring showed larger effects (SMD -0.88)
- •Mechanisms: GABA elevation, reduced neuronal firing, improved mitochondrial function, reduced neuroinflammation
- •Complete remission case series published in PMC — several patients achieved full depression/anxiety remission on ketogenic diet
- •Alzheimer's increasingly framed as metabolic disease — ketones as alternative brain fuel
Practical Implication
The evidence is promising but not yet Canon-level. Worth watching as metabolic psychiatry matures. The JAMA publication lends real credibility — this is not fringe science anymore.
Nuance & Limits
Effect sizes are small-to-medium, not large. Anxiety results are mixed. Ketogenic diets are difficult to sustain long-term and can have side effects (kidney stress, nutrient deficiencies, social difficulty). Most studies are short-duration. The "quieting the mind" framing from podcast discourse may overstate what the research actually shows. This is a Curious idea approaching Canon — needs more and larger RCTs.
Source Material
Citation Density
Moderate — D'Agostino has been on Ferriss multiple times, Huberman has covered ketosis. The JAMA meta-analysis (2025) is the strongest single citation.
Related Ideas
Both claim to 'quiet the mind' — meditation through attentional training, ketosis through neurochemistry
Both are metabolic interventions that affect mental health — exercise through multiple pathways, ketosis through GABA and mitochondrial function